Sign up to receive Dana-Farber Spotlight, our email newsletter.View the current issueSubscribe nowUnsubscribe from mailings
Ellen BerlinDirector of Media Relations617firstname.lastname@example.org
Molly McHaleAssociate Director of Media Relations617email@example.com
Steven Chang led a study showing robotic surgery for
prostate cancer may have led to changes in the number of surgeons performing
prostate removals and in the overall cost.
A new program called CaNCURE is a unique partnership between the Initiative
to Eliminate Cancer Disparities at Dana-Farber/Harvard Cancer Center and
Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
Dr. Robert Haddad discussed former Red Sox pitcher Curt Schilling’s oral cancer diagnosis
during the WEEI/NESN Jimmy Fund Radio-Telethon.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: